KP Tissue Inc. (KPTSF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 13.73 means the share price is 13.73 times one year of earnings per share. Market cap $86.6M is the value of all shares combined. Beta 0.38: the stock has moved about 62% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerKP Tissue Inc. (KPTSF) trades at $8.63. KP Tissue Inc. is a leading manufacturer and distributor of disposable tissue products in Canada and the United States. Market cap: $86.6M, Sector: Consumer staples.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for KPTSF: KPTSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
KP Tissue Inc. (KPTSF) Consumer Business Overview
KP Tissue Inc., operating through Kruger Products L.P., is a key player in the North American disposable tissue market. With a diverse brand portfolio and established distribution channels, the company caters to both consumer and commercial segments, navigating a competitive landscape with a focus on established brands and private label offerings.
What Is the Investment Thesis for KPTSF?
The company's consistent dividend yield of 6.64% offers an attractive income stream for investors. While the company's P/E ratio of 13.73 suggests a premium valuation, the low beta of 0.38 indicates lower volatility compared to the broader market. Growth catalysts include expansion within the Away-From-Home segment and potential for increased private label manufacturing. However, investors should be aware of risks associated with raw material price fluctuations and competitive pressures within the tissue market. The company's ability to maintain brand strength and optimize operational efficiency will be crucial for sustained profitability.
Based on FMP financials and quantitative analysis
KPTSF Key Highlights
Market capitalization of $86.6M indicates a small-cap company.
- P/E ratio of 13.73 reflects the company's earnings relative to its stock price.
- Beta of 0.38 suggests lower volatility compared to the overall market.
- Dividend yield of 6.64% provides a significant income stream for investors.
- Operates in the Consumer Defensive sector, which is generally considered stable during economic downturns.
Who Are KPTSF's Competitors?
KPTSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CHFHY China Foods Limited | $10.23 | 0.00% | $1.43B | — |
| CHUC Charlie's Holdings, Inc. | $0.09 | +44.52% | $24.4M | — |
| MJWNY Naked Wines plc | $3.60 | 0.00% | $59.5M | — |
| SKIN The Beauty Health Company | $12.15 | -2.49% | $79.2M | — |
| SLSN Solésence, Inc. | $1.48 | -9.76% | $105M | 64 5-pillar |
| NUS Nu Skin Enterprises, Inc. | $3.77 | -2.58% | $184M | 35 5-pillar |
| GROV Grove Collaborative Holdings, Inc. | $0.94 | +16.05% | $40.4M | — |
| UG United-Guardian, Inc. | $7.15 | -6.41% | $32.9M | 83 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KPTSF's Key Strengths?
Strong brand recognition for key product lines.
- Established distribution network in North America.
- Diversified product portfolio catering to both consumer and commercial markets.
- Consistent dividend yield providing investor income.
What Are KPTSF's Weaknesses?
Reliance on Kruger Products L.P. for revenue generation.
- Exposure to fluctuations in raw material prices.
- Limited geographic diversification beyond North America.
- Small market capitalization compared to larger competitors.
What Could Drive KPTSF Stock Higher?
KPTSF catalyst: Expansion in the Away-From-Home segment, driven by increased demand for hygiene products in commercial settings.
- Focus on sustainable and eco-friendly products, attracting environmentally conscious consumers.
- Potential for new private label manufacturing contracts with major retailers.
- Product innovation and launch of new tissue products with enhanced features.
- Consistent dividend yield providing an attractive income stream for investors.
What Are the Key Risks for KPTSF?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger players in the tissue market, potentially impacting market share and profitability.
- Fluctuations in raw material prices, such as pulp and paper, affecting production costs and margins.
- Economic downturns impacting consumer spending on non-essential household products.
- Changes in consumer preferences and demand for sustainable products, requiring adaptation and investment.
- Risks associated with operating in the OTC market, including limited liquidity and regulatory oversight.
What Are the Growth Opportunities for KPTSF?
- Expansion in the Away-From-Home Segment: The Away-From-Home segment presents a significant growth opportunity for KP Tissue. As businesses and public facilities increasingly focus on hygiene and cleanliness, the demand for disposable tissue products in this segment is expected to rise. By strengthening its distribution network and tailoring its product offerings to meet the specific needs of commercial users, KP Tissue can capture a larger share of this growing market. The global away-from-home tissue market is projected to reach $30 billion by 2028.
- Increased Private Label Manufacturing: KP Tissue can leverage its manufacturing capabilities to expand its private label business. Retailers are increasingly seeking private label partnerships to offer cost-effective alternatives to branded products. By offering competitive pricing and high-quality products, KP Tissue can attract new private label contracts and increase its overall production volume. This strategy can also help the company diversify its revenue streams and reduce its reliance on branded product sales. The private label market is estimated to be around $200 billion.
- Product Innovation and Differentiation: Investing in product innovation and differentiation is crucial for KP Tissue to maintain its competitive edge. Developing new tissue products with enhanced features, such as increased absorbency, softness, or eco-friendliness, can attract new customers and retain existing ones. The company can also explore innovative packaging solutions and marketing campaigns to differentiate its products from competitors. Ongoing research and development efforts are essential for staying ahead of market trends and meeting evolving consumer needs. The tissue market sees hundreds of new product launches every year.
- Geographic Expansion within North America: While KP Tissue already has a presence in Canada and the United States, there is potential for further geographic expansion within these markets. Identifying underserved regions or demographic segments and tailoring its product offerings to meet their specific needs can drive sales growth. The company can also explore strategic partnerships with local distributors to expand its reach and market penetration. Market research and analysis are essential for identifying promising geographic expansion opportunities.
- Focus on Sustainable and Eco-Friendly Products: With growing consumer awareness of environmental issues, there is increasing demand for sustainable and eco-friendly tissue products. KP Tissue can capitalize on this trend by investing in sustainable sourcing practices, reducing its environmental footprint, and developing eco-friendly products. This can enhance the company's brand image, attract environmentally conscious consumers, and gain a competitive advantage in the market. The global market for sustainable paper products is projected to reach $40 billion by 2027.
What Are KPTSF's Competitive Advantages?
- Established brand portfolio with well-known brands like Cashmere, Purex, and SpongeTowels.
- Extensive distribution network across Canada and the United States.
- Manufacturing capabilities for both branded and private label products.
- Long-standing relationships with retailers and distributors.
What Does KPTSF Do?
KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada. The company's primary asset is its investment in Kruger Products L.P., a leading manufacturer and distributor of disposable tissue products. Kruger Products L.P. traces its roots back to the early 20th century, evolving from a pulp and paper business into a consumer-focused tissue product company. KP Tissue operates through two segments: Consumer and Away-From-Home. The Consumer segment focuses on retail channels, offering products like bathroom tissue, facial tissue, paper towels, and napkins under well-known brands such as Cashmere, Purex, SpongeTowels, and Scotties. The Away-From-Home segment caters to commercial users, including property management, healthcare, food services, manufacturing, lodging industries, and public facilities, providing tissue products through distributors. The company also manufactures private label tissue products for various retailers. KP Tissue distributes its products through traditional retail channels, including grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers. The company's geographic focus is primarily Canada and the United States.
What Products and Services Does KPTSF Offer?
- Produces bathroom tissue for consumer use.
- Manufactures facial tissues for various needs.
- Creates paper towels for household and commercial cleaning.
- Offers napkins for both consumer and away-from-home markets.
- Manufactures private label tissue products for retailers.
- Distributes tissue products through retail channels.
- Supplies tissue products to commercial users through distributors.
How Does KPTSF Make Money?
- Manufactures and sells disposable tissue products.
- Generates revenue through sales to consumers via retail channels.
- Generates revenue through sales to commercial users via distributors.
- Offers private label manufacturing services to retailers.
What Industry Does KPTSF Operate In?
KP Tissue Inc. operates within the competitive household and personal products industry, specifically focusing on the disposable tissue segment. The market is characterized by stable demand, driven by essential consumer needs. Key trends include a growing emphasis on sustainable and eco-friendly products, as well as increasing demand for private label brands. The company competes with larger players like CHFHY (Cascades Inc.), CHUC (Church & Dwight Co.), HWIN (Howe Sound Pulp and Paper Limited), MJWNY (Mcj Paper), and NWINF (Northwest Innovation Works Inc.) who have significant market share and brand recognition. KP Tissue's success depends on its ability to maintain brand loyalty, innovate with new products, and efficiently manage its supply chain.
Who Are KPTSF's Key Customers?
- Consumers purchasing tissue products for household use.
- Businesses and organizations in the property management, healthcare, food services, manufacturing, and lodging industries.
- Retailers seeking private label tissue products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
Company Profile
KP Tissue Inc. operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Mississauga, CA. The company is led by CEO Dino J. Bianco. KPTSF has traded publicly since 2015.
Financial Health
KP Tissue Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 33.61 places it in the safe zone, indicating low near-term bankruptcy risk.
Key Financial Metrics
Return on equity for KP Tissue Inc. stands at 12.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 12.3%, showing how much profit it generates from its asset base. KPTSF trades at a trailing price-to-earnings ratio of 13.73, below the Consumer Defensive sector average of ~28.20x. A current ratio of 1.00 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 7.3%, the inverse of the P/E and a quick read on earnings relative to price.
KPTSF Valuation & Market Position
With a $86.6M market cap, KP Tissue Inc. sits in the micro-cap segment of the market.
Earnings Track Record
KP Tissue Inc. has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 23.2% above estimates on average.
KPTSF Financials
Bull Case vs Bear Case
Bull Case
- Strong brand recognition for key product lines.
- Established distribution network in North America.
- Diversified product portfolio catering to both consumer and commercial markets.
- Consistent dividend yield providing investor income.
Bear Case
- Reliance on Kruger Products L.P. for revenue generation.
- Exposure to fluctuations in raw material prices.
- Limited geographic diversification beyond North America.
- Small market capitalization compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
KPTSF Latest News
-
KP Tissue Inc (KPTSF) (Q3 2026) Earnings Call Highlights: Strong EBITDA Growth and Margin ...
Yahoo! Finance: KPTSF News · Nov 11, 2026
-
KP Tissue Releases Third Quarter 2026 Financial Results
TMX Newsfile · Nov 11, 2026
-
RETRANSMISSION: KP Tissue to Release Its Financial Results and Those of Kruger Products Inc. for the Third Quarter of 2026
Yahoo! Finance: KPTSF News · Nov 10, 2026
-
RETRANSMISSION: KP Tissue to Release Its Financial Results and Those of Kruger Products Inc. for the Third Quarter of 2026
TMX Newsfile · Nov 10, 2026
KPTSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for KPTSF.
Price Targets
Wall Street price target analysis for KPTSF.
KPTSF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for KPTSF; grades run from A+ (80-100) to F (below 30).
Latest News
KP Tissue Inc (KPTSF) (Q3 2026) Earnings Call Highlights: Strong EBITDA Growth and Margin ...
KP Tissue Releases Third Quarter 2026 Financial Results
RETRANSMISSION: KP Tissue to Release Its Financial Results and Those of Kruger Products Inc. for the Third Quarter of 2026
RETRANSMISSION: KP Tissue to Release Its Financial Results and Those of Kruger Products Inc. for the Third Quarter of 2026
Leadership: Dino J. Bianco
CEO
Dino J. Bianco is the Chief Executive Officer of KP Tissue Inc. and Kruger Products L.P. His career spans various leadership roles within the consumer packaged goods industry. Prior to joining Kruger Products, he held senior positions at Kraft Heinz Canada and was President of Kraft Canada. He brings extensive experience in brand management, sales, and marketing. His background includes a strong focus on driving growth and innovation within established consumer brands.
Track Record: Since assuming the role of CEO, Dino J. Bianco has focused on strengthening KP Tissue's market position and driving operational efficiencies. Key initiatives include expanding the company's presence in the Away-From-Home segment and investing in product innovation. Under his leadership, the company has maintained a consistent dividend payout and navigated a competitive market landscape.
KPTSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that KPTSF may have limited regulatory oversight and disclosure requirements compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies in this tier may not meet the minimum financial standards or reporting requirements necessary for listing on higher-tier exchanges. This tier is often associated with increased risk due to the potential for less transparency and greater price volatility.
- OTC Tier: OTC Other
- Limited regulatory oversight and disclosure requirements.
- Lower trading volumes and wider bid-ask spreads.
- Potential for price volatility and manipulation.
- Increased risk of fraud or misrepresentation.
- Difficulty in obtaining reliable information about the company.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Established business operations with a history of revenue generation.
- Recognizable brand names and products.
- Presence in traditional retail channels.
- Consistent dividend payments to shareholders.
- Management team with experience in the consumer packaged goods industry.
Common Questions About KPTSF (Consumer Staples)
Is KPTSF a good stock to buy?
Stock Expert AI does not rate KPTSF buy, sell or hold. KP Tissue Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the KPTSF stock price today?
The last price recorded on this page for KP Tissue Inc. (KPTSF) is $8.63, as of the Nov 19, 2026 trading session. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for KPTSF?
The main risks for KPTSF include intense competition in the tissue market, fluctuations in raw material prices, and potential economic downturns impacting consumer spending. The company's reliance on Kruger Products L.P. for revenue generation also presents a concentration risk.
What are the key factors to evaluate for KPTSF?
Evaluate KPTSF on fundamentals, analyst consensus, and risk factors. P/E: 13.73x. The company's consistent dividend yield of 6.64% offers an attractive income stream for investors. Not financial advice.
How frequently does KPTSF data refresh on this page?
KPTSF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven KPTSF's recent stock price performance?
KP Tissue Inc. (KPTSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand recognition for key product lines. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KPTSF overvalued or undervalued right now?
KP Tissue Inc. (KPTSF) trades at 13.73x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research KPTSF before investing?
Before investing in KP Tissue Inc. (KPTSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.